Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v1-EN
Language English English
Date Updated 2024-11-13 2024-09-16
Drug Identification Number 00386685 00386685
Brand name LIPIODOL ULTRA FLUID LIPIODOL ULTRA FLUID
Common or Proper name Ethiodized Oil Injection Ethiodized Oil Injection
Company Name GUERBET GUERBET
Ingredients IODINE IODINE
Strength(s) 380MG 380MG
Dosage form(s) LIQUID LIQUID
Route of administration PARENTERAL (UNSPECIFIED) INTRACAVITARY INTRACAVITARY PARENTERAL (UNSPECIFIED) PARENTERAL (UNSPECIFIED) INTRACAVITARY INTRACAVITARY PARENTERAL (UNSPECIFIED)
Packaging sizes (GTIN) (See additional packaging sizes) (See additional packaging sizes)
Additional packaging sizes 10 mL 10 mL
ATC code V08AD V08AD
ATC description X-RAY CONTRAST MEDIA, IODINATED X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2024-10-01 2024-10-01
Actual start date
Estimated end date Unknown Unknown
Actual end date 2024-11-13
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments Shortage resolved The manufacturer is facing manufacturing delays. Product is currently under allocation.
Health Canada comments